BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37356939)

  • 21. [Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma].
    Yan J; Zhou DM; Shao XY; Xu Y; Chen B
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):170-177. PubMed ID: 38604794
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy and prognostic analysis of orthopedic surgery in patients with newly diagnosed multiple myeloma].
    Zhang FJ; Zhou X; Liu SZ; Liu SJ; Liu Y; Zhuang JL
    Zhonghua Nei Ke Za Zhi; 2023 Jun; 62(6):673-680. PubMed ID: 37263950
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correlation between Peripheral Blood PLR with Treg, Th17 in Newly Diagnosed Multiple Myeloma and Its Influence on Prognosis].
    Qin N; Feng RT; Wang X; Guo SX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1757-1763. PubMed ID: 38071057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 25. High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.
    Gu Y; Yuan YH; Xu J; Shi QL; Qu XY; Guo R; Bai H; Xu JD; Li JY; Chen LJ
    Oncotarget; 2017 Jul; 8(29):48350-48361. PubMed ID: 28418851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of IgG Levels at Initial Diagnosis with Clinical Efficacy and Prognosis in 66 Patients with IgG Multiple Myeloma].
    Nian FG; Li F; Shao LJ; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1159-1165. PubMed ID: 31418373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.
    Pan Y; Wang H; Tao Q; Zhang C; Yang D; Qin H; Xiong S; Tao L; Wu F; Zhang J; Zhai Z
    Leuk Res; 2016 Jan; 40():77-82. PubMed ID: 26597998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the number of high-risk cytogenetic abnormalities on the clinical characteristics and prognosis in 360 patients with newly diagnosed multiple myeloma].
    Chen Z; Xia Y; Guo R; Zhang R; Qiu HR; Jin YY; Li JY; Chen LJ
    Zhonghua Xue Ye Xue Za Zhi; 2022 May; 43(5):408-413. PubMed ID: 35680599
    [No Abstract]   [Full Text] [Related]  

  • 29. [Expression of CD56 in Multiple Myeloma Cells and Its Relationship with Extramedullary Disease and Extramedullary Relapse].
    Li G; Huang XJ; Niu T; Wei C; Cheng MX; Han CJ; Sun YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):553-556. PubMed ID: 33812430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Value of Serum HMGB1 and sRAGE in the Diagnosis, Efficacy Monitoring and Prognosis of Newly Diagnosed Multiple Myeloma].
    Wang J; Zeng AM; Liang SF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):493-500. PubMed ID: 35395985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
    Qiu Q; Zhu P; Wang MJ; Lu XZ; Dong YJ; Sun YH; Wang LH; Zhang Y; Bu DF; Wang WS; Liang ZY; Liu W; Qiu ZX; Ou JP; Cen XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1071-8. PubMed ID: 27531777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China.
    Chen Q; Han X; Zheng G; Yang Y; Li Y; Zhang E; Yang L; Dong M; He D; He J; Cai Z
    Front Oncol; 2022; 12():1084683. PubMed ID: 36605445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease.
    Wang J; Shen N; Shen X; Zhang R; Jin Y; Li J; Chen L
    Ann Med; 2023; 55(2):2281657. PubMed ID: 38086395
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
    Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].
    Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas.
    He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
    Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical features and outcome analyses of newly-diagnosed multiple myeloma with extramedullary involvements].
    Zhang YZ; Zhi YQ; Wang YF; Yu Y; Zhao ZG; Wang XF; Zhai QL; Sun BC
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2415-8. PubMed ID: 23158665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic Value of Pre-treatment Albumin/Fibrinogen Ratio in Patients with Diffuse Large B-cell Lymphoma].
    Deng H; Zhang L; Wang HY; Huang MJ; Wei J; Zou XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):762-768. PubMed ID: 37356937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Influence of Serum Homocysteine Level to the Prognosis of Newly Diagnosed Multiple Myeloma Patients and Analysis of Related Factors].
    Fu Y; Wei XF; Feng YF; Liu F; Chen QL; Zhao YY; Zhang WJ; Ma T; Huang XJ; Chen Y; Li QF; Zhang QK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):530-534. PubMed ID: 33812426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the clinical effects and outcome of patients with double-hit high-risk multiple myeloma].
    Liu S; Shang J; Lin Y; Wang ZH; Wei TN; Lin L; Yang T; Chen WM
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1209-1214. PubMed ID: 34794226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.